- Singular Genomics Systems (NASDAQ:OMIC) fell for a third straight session Friday, erasing all of the big gains that the biotech saw in its first few trading days following what had seemed like a well-received IPO.
- OMIC sank to a post-IPO intraday low of $24.18 Friday before partly recovering to end the session at $25.47, down 8.2% on the day and 18.3% since Tuesday’s close.
- Friday’s finish completely wiped out all remaining gains from a 24.4% pop that Singular enjoyed on its first trading day last…
Click here to view the original article.
